Earnings Feed
Start Free
Home/Filings/4/0001077183-23-000121
4//SEC Filing

HANNAH ALISON L. 4

Accession 0001077183-23-000121

CIK 0001077183other
View on SEC.govCompany Profile

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 5:41 PM ET

Size

13.8 KB

Accession

0001077183-23-000121

Insider Transaction Report

Form 4
Period: 2023-08-10
NEOGENOMICS INCNEO
HANNAH ALISON L.
Director
Transactions
  • Award

    Restricted Stock Unit

    2023-08-10+11,336→ 11,336 total
    Exercise: $0.00From: 2024-08-10→ Common Stock (11,336 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-08-10+8,353→ 8,353 total
    Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying)
Holdings

  • Common Stock

    107,433

  • Stock Option (Right to Buy)

    Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
    4,269

  • Stock Options (Right to Buy)

    Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying)
    3,448

  • Stock Option (Right to Buy)

    Exercise: $8.10From: 2023-06-10Exp: 2029-06-10→ Common Stock (13,882 underlying)
    13,882

  • Stock Option (Right to Buy)

    Exercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying)
    3,017

  • Stock Option (Right to Buy)

    Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying)
    3,714
Footnotes (1)
  • [F1]Once vested, the shares of common stock are not subject to expiration.

Documents

1 file

Issuer

NEOGENOMICS INC

CIK 0001077183

→
Entity typeother

Related Parties

1
  • filerCIK 0001645600

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:41 PM ET
Size
13.8 KB
View on SEC.gov